Sean Tribull, our Hospitality & Leisure Lead, has launched Suite Talk, a new series for the Venari Podcast covering the latest insights on hospitality leadership. His second guest is Barbara Muckermann, CEO of Kempinski Hotels.
Sean Tribull, our Hospitality & Leisure Lead, has launched Suite Talk, a new series for the Venari Podcast covering the latest insights on hospitality leadership. His first guest is Orient Express Group CEO and Chief Strategy Officer at Accor, Gilda Perez-Alvarado.
In this episode of the HealthTech CEO series, Venari Partners Senior Consultant Cristian Owen speaks with Jens Noerterhaeuser, CEO & Co-founder of Kranus Health
Nuclear medicine is finally having its moment. Radiopharmaceuticals are poised to bring about a sea change in the treatment of cancer – though to make sure innovation in the space remains at the cutting edge, having the right talent is arguably the single most important aspect. It was this topic that led Ken Herrmann and Valentina Ambrosini, from Essen University Hospital and the University of Bologna respectively, to co-author an article for the European Journal of Nuclear Medicine and Molecula...
‘Employee engagement remains such an important part of the work that we do as HR leaders – and, really, as business leaders,’ says Amy Rodgers. She’s been Chief Human Resources Officer at PPC Flexible Packaging since November 2022, and has plenty of wisdom to share about managing talent in the packaging space. Tim Hartnell, Senior Consultant for our Sustainable Packaging practice, caught up with Amy on this episode of the Venari Podcast. Here are some of the key things we learned from their conv...
‘I’ve always really loved the biotech space,’ says Sonya Montgomery. An experienced Chief Medical Officer (CMO) with a strong focus on genomic medicine for rare diseases, Sonya has over 20 years of experience developing drugs across the US, Canada, the UK, and the Netherlands. Having most recently worked at Evox Therapeutics, Sonya has also offered her services as an independent consultant for the past decade. Paula Doust Alba, CNS & Rare Disease Consultant for our Life Sciences team, was de...
Matthew Palmer, Senior Oncology Consultant for our life sciences practice, caught up with ARTBIO CEO Emanuele Ostuni for this episode of the Venari Podcast. You can read the transcript of the interview below for more on Emanuele’s career, what ARTBIO are working on, the challenges of being a CEO, and his thoughts on building teams for success.
It’s fair to say that Tiffany Olson has always kept herself busy. ‘When other girls were playing Barbie, I played store and I was making a profit at five years old,’ she notes. Tiffany took her entrepreneurial spirit and drive to the pharmaceutical industry, where an early taste of working life was enough to give her the bug: ‘Once I saw and experienced that patient impact, I was hooked on this industry. And I’ve stayed in it my entire career.’ Tiffany told Matt Palmer, Senior Oncology Consultan...
Matthew Palmer, Senior Oncology Consultant for our Life Sciences team, caught up with Ian for the first episode of ‘Talking Radiopharma’, Matthew’s new series for the Venari Podcast. Read on for Ian’s thoughts on life as a CEO, ImaginAb’s R&D in theragnostics, and key challenges the company looks set to face going forward. Ian also has some fascinating insights on team building, the key skillsets he looks for in talent, and advice for budding scientists and developers in his nuclear medicine...
‘One of the things I’ve learned is you’re only as good as your team’. Michael Ferguson joined Abivax as Chief Commercial Officer earlier this year, since then they’ve IPO’d on Nasdaq (largest French Biotech IPO ever - $212m) and Michael has been building and shaping the commercial strategy and team. We discuss all this and more in the next episode of The Venari Podcast – have a listen!
‘I’m a huge proponent for working in large, established companies earlier in one’s career.’ With an enviable track record across Big Pharma and small biotechs, it’s worth noting what Rani Therapeutics’ Chief Business Officer, Kate McKinley, has to say – which is why Joe Knight, Commercial Consultant for our Life Sciences practice, invited her to appear on an episode of the Chief Commercial Officer series for the Venari Podcast. Read on for more on their conversation on commercial strategy in lif...
Mohamed Issa knows all about what is needed for successful life sciences launches. Before his current role as SVP of Immunology at Janssen, he held varied positions – including juggling the foundation and successful exit of Noor Pharmaceuticals at the same time as his previous day job – making him more than qualified to discuss launches both at startup and Big Pharma level. Joe Knight caught up with Mohamed to gear his thoughts on leadership, team building, and the decisions that made him the ex...
‘Technology changes fast – and I like that. I think the people that are in it for a long time enjoy that.’ With over 25 years of experience working in technology, Joel Goldberg has seen trends come and go – but, for him, some working principles remain constant. They’ve served him well over a varied and successful career, which has taken in a number of C-level positions at various companies, including Chief Digital Officer at WizzAir most recently. Tom Woods, our Senior Digital & Technology C...
Consulting gave Rachel Goldberg has ‘a helicopter view of different aspects of business’ early in her professional life – though the chance to work on longer-term projects in retail was tempting. Over the course of a career that’s taken in stints in consulting as well as household names in retail, Rachel accrued vast experience of both sectors prior to attaining her current role as Group Head of Strategy at Currys. Rachel spoke to Mhairi Geraghty, our Senior Interim Solutions Consultant, on the ...
‘Am I happy in the work that I’m doing, and am I growing and developing? I think when I’ve answered “No” to either of those questions is when I found it’s the right time to make a change.’ Emma Butler has enjoyed a varied career that has taken in stints at Deloitte, the BBC, and Burberry. Now, she has transitioned from finance and auditing into a transformation role, as Commercial Transformation Lead at Mulberry. Mhairi Geraghty, our Senior Interim Solutions Consultant, caught up with Emma on th...
Christian Tullberg Poulsen’s journey as a HealthTech founder began when a friend gave him an old device for training the lungs of people suffering from asthma and COPD. He gave it to some classical singers – and when the quality and pitch of their singing improved, Christian didn’t waste any time, buying worldwide rights and stock of the device to sell to singers. Now, the Airofit has proven beneficial for weekend warriors, athletes – and even long COVID sufferers. In this episode of the Venari ...
‘In order to empower people, of course you need to trust them.’ Sevinç Yener has over 25 years’ experience in executive management – and now, as CEO of Mondi Corrugated, she must navigate the challenges of providing effective sustainable packaging solutions in a challenging economic climate, with plenty of competitors. It’s been a success so far – and Tim Hartnell, our Senior Sustainable Packaging Consultant, heard the reasons why when he spoke to Sevinç on the Venari Podcast. Check out the full...
‘Number one, at the end of the day, is understanding who our end consumer is.’ Akhil Anumolu’s career has taken in digital product management, engineering, commercial strategy and digital marketing. As Vice President of Global Digital Product Management and Engineering at a renowned global fast food chain, he helps to shape the company’s digital transformation and innovation all over the world. Tom Woods, Senior Consultant for our Digital & Technology team, got Akhil’s thoughts on team build...
‘I think an appreciation for translational research has really started to emerge over the past few years.’ Dr Chris Winrow has had an excellent vantage point from which to observe how approaches to translational research have changed in recent years. An expert in neurodegenerative disease, with over 20 years’ experience in pharma and biotech in a variety of research, translational, and clinical roles, he joined Lucy Therapeutics as CSO in March 2023. Paula Doust Alba, our CNS & Rare Disease ...
'Serendipity and interests combined' - talking healthcare startups with Fount CEO Andrew HerrAndrew joined us on the Venari Podcast to discuss what he’s learned across his career.
‘You can’t afford to drag with suboptimal performance.’Johanna Rossell, SVP General Manager Rare Diseases at Sumitomo Pharma America, has a wide range of professional experience to draw on when it comes to commercial biopharma. Her career has taken in stints in marketing and commercial across South America, Switzerland, and the US for a number of large companies prior to her recent experience as CCO of Enzyvant. Joe Knight, our Life Sciences Commercial Consultant, welcomed Johanna to the Venari ...
With over 20 years’ experience of leadership roles in multiple sectors across the globe, Lance Burn is more than qualified to talk about what it takes to reach the C-suite. In this episode of the Venari Podcast, Lance – who was most recently CEO of IG Design Group , where he was responsible for a business unit worth $650 million – spoke to our Senior Sustainable Packaging Consultant, Tim Hartnell , about leadership, team dynamics, and why he’s optimistic about the coming months....
Dr. Tatiana Fofanova’s journey towards establishing Koda Health took off in earnest during COVID. She was inspired to provide a patient-facing web application for users without access to certain treatments and medical documents. Despite the necessity of such offerings, however, startup life has been a rollercoaster ride – particularly as female-founded companies rarely get the same levels of investment as male-founded ones... Tatiana spoke to Cristian Owen, our Specialist Digital Health Consulta...
Dr Dean Carson’s professional expertise in neuroscience spans preclinical research, clinical development, medical affairs, and business operations. A neuroscientist and psychopharmacologist by training, he earned his PhD at the University of Sydney and did postdoctoral work at Stanford before leaving academia for industry to work in small, early-stage biotechs. Dean has held multiple operational, clinical, and scientific leadership positions, resulting in successful exits, funding, and drug appr...
In the next episode of the Chief Commercial Officer Series on the Venari Podcast, Joe Knight, who leads the Commercial function within the Life Sciences and Healthcare practice at Venari Partners, was joined by Everett Crosland, Chief Commercial Officer at Cognito Therapeutics. This isn't Everett's first CCO gig; he was previously CCO at AppliedVR and has a strong pricing and access background across both large and small organizations. In this podcast episode, they talked about building high-per...
‘Let's be transparent so that people can learn.' Amy Mahery has over 20 years’ experience in multiple commercial roles in Big Pharma and biotech. Now, as CCO of Roivant Sciences, she’s responsible for the company’s commercial strategy as they build out their team and develop their leadership talent. Joe Knight, our Life Sciences Commercial Consultant, was delighted to welcome Amy to the Venari Podcast for an episode of the Chief Commercial Officer series, where they discussed launch strategies, ...
What advice does Mycovia Pharmaceuticals CCO Tiffany Ahlers have for aspiring executives? ‘Take every experience given to you. A lot of times, I would take on additional responsibilities or roles [...] I got exposure to other areas of the business.’ Our Life Sciences consultant, Joe Knight, was delighted to welcome Tiffany to our Chief Commercial Officer series for the Venari Podcast recently. Check out the full episode now!
"External consultants can be a great way of bridging the capability gap". Independent consultant and McKinsey alumnus Dr. Robert L. recently sat down with Senior Consultant in our Interim practice, Mhairi Geraghty, to give his thoughts on how to scope a project or interim need. He shares what good (and bad) looks like, and what it takes to increase the chances of your project’s success.
Rhenus Logistics’ Head of Ocean Freight Americas spoke about the current market and future of the logistics industry on the Venari Podcast.
Having worked on 15 different launches in nine different therapeutic areas – and in varying leadership roles – Lauren D'Angelo, MBA has ample experience in the commercial side of life sciences. Now, as CCO of CNS (central nervous system) start-up Alpha Cognition, Inc., she focuses on developing corporate strategy – but what are the most important lessons she’s learned from building out commercial teams?Lauren spoke to Joe Knight, our Life Sciences & Healthcare Commercial Lead, as part of our...
